Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

223
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
223
Drug Elimination: The Concept of Clearance01:06

Drug Elimination: The Concept of Clearance

3.0K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
3.0K
Radical Formation: Elimination00:51

Radical Formation: Elimination

1.9K
Another method of radical formation is the elimination process. It is the opposite of the addition route and is driven by the instability of the radical. For example, as depicted in Figure 1, dibenzoyl peroxide yields a pair of unstable radicals upon homolysis. Given its instability, this radical spontaneously undergoes elimination via a C–C bond cleavage to form a relatively more stable phenyl radical. The mechanism involves cleavage of the bond between the α and β positions...
1.9K
Elimination Reactions02:25

Elimination Reactions

13.9K
A nucleophile can react with an alkyl halide to give the substitution product by displacing the halogen. Or it can function as a base to give the elimination product by deprotonation of the neighboring carbon to form an alkene. In an elimination reaction, the substrate loses two groups from adjacent carbons forming at least one π bond. The carbon attached to the halogen is called the α carbon, while the adjacent carbon is called the β carbon; hence, these reactions are called...
13.9K
Deleterious Substances in Aggregate01:25

Deleterious Substances in Aggregate

246
Deleterious substances in aggregates can be detrimental to the quality and durability of concrete. These substances include organic impurities like loam, which interfere with cement hydration and are usually present in the sand. These prevent a good bond between aggregate and cement paste. Organic impurities can be detected using the colorimetric test, where the darkness of a solution after agitation indicates the level of organic content.
Another type of impurity is clay and fine material that...
246
Wald-Wolfowitz Runs Test I01:17

Wald-Wolfowitz Runs Test I

738
The Wald-Wolfowitz test, also known as the runs test, is a nonparametric statistical test used to assess the randomness of a sequence of two different types of elements (e.g., positive/negative values, successes/failures). It examines whether the order of the elements in a sequence is random or if there is a pattern or trend present. This nonparametric test applies to any ordered data despite the population and sample data distribution, even if a higher sample size is available.
The test works...
738

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Risk of Intra-Amniotic Infection After Cervical Ripening Balloon for Prelabor Rupture of Membranes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Risk of Severe Coronavirus Disease 2019 (COVID-19) in Pregnant and Postpartum Individuals After the Pandemic Emergency.

Obstetrics and gynecology·2026
Same journal

Long-Term Outcomes After Native Tissue Hysteropexy Compared With Hysterectomy for Treatment of Pelvic Organ Prolapse.

Obstetrics and gynecology·2026
Same journal

Association of Glucagon-Like Peptide-1 Receptor Agonists With Menstrual Events in Reproductive-Aged Patients.

Obstetrics and gynecology·2026
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026

Related Experiment Video

Updated: Sep 9, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Elimination of the DATA-Waiver Program

    Obstetrics and Gynecology
    |September 4, 2025
    PubMed
    Summary

    The DATA-Waiver program for prescribing buprenorphine has been eliminated. This update provides revised clinical guidance for healthcare professionals managing opioid use disorder in pregnant patients.

    Area of Science:

    • Obstetrics and Gynecology
    • Addiction Medicine
    • Pharmacology

    Background:

    • The Drug Addiction Treatment Act (DATA) Waiver program previously regulated buprenorphine prescribing.
    • Updates to federal regulations have eliminated the need for a separate waiver to prescribe buprenorphine.
    • Existing clinical guidance requires focused updates to reflect these regulatory changes.

    Purpose of the Study:

    • To provide revised clinical practice guidance on managing opioid use and opioid use disorder in pregnancy.
    • To incorporate the elimination of the DATA-Waiver program into clinical recommendations.
    • To update Committee Opinion No. 711 regarding pharmacologic treatment for opioid use disorder in pregnant individuals.

    Main Methods:

    • Focused review and revision of existing clinical practice guidelines.

    More Related Videos

    Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
    07:46

    Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

    Published on: October 22, 2015

    14.6K
    Extinction Training During the Reconsolidation Window Prevents Recovery of Fear
    11:17

    Extinction Training During the Reconsolidation Window Prevents Recovery of Fear

    Published on: August 24, 2012

    35.6K

    Related Experiment Videos

    Last Updated: Sep 9, 2025

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
    06:55

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

    Published on: January 8, 2020

    14.6K
    Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
    07:46

    Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

    Published on: October 22, 2015

    14.6K
    Extinction Training During the Reconsolidation Window Prevents Recovery of Fear
    11:17

    Extinction Training During the Reconsolidation Window Prevents Recovery of Fear

    Published on: August 24, 2012

    35.6K
  • Integration of updated regulatory information concerning buprenorphine prescribing.
  • Consultation with expert committees to ensure current best practices are reflected.

    • Main Results:

    • The elimination of the DATA-Waiver program simplifies access to medication for opioid use disorder.
    • Healthcare providers no longer require a specific waiver to prescribe buprenorphine for opioid use disorder.
    • Revised guidance emphasizes evidence-based treatment for opioid use disorder in pregnancy.

    Conclusions:

    • Clinicians should be aware of the elimination of the DATA-Waiver program.
    • Updated guidance supports expanded access to medication-assisted treatment for pregnant patients with opioid use disorder.
    • Continued adherence to best practices in managing opioid use disorder during pregnancy is crucial.